Drug targets for lipid modification and risk of type 2 diabetes: a cis-Mendelian randomization study.

Cardiovasc Diabetol · 2026 · PMC13344049 · PMID 42135799

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

nominally significantno p-value reported

3 , S1, Table S3), but generally inconclusive with only borderline nominally significant effects and poor evidence of colocalization.

also in 7,732 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.